Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Am J Transplant. 2019 Aug 7;19(11):3058–3070. doi: 10.1111/ajt.15496

Table 4.

Number of deceased donor kidney transplants performed from January 1, 2015 to June 30, 2018 by transplant program using HCV seropositive non-viremic (HCV D Ab+, NAT −) and HCV Viremic donors (HCV D Ab±, NAT+) for HCV uninfected recipients (R Ab −).

HCV D Ab+, NAT −/ R Ab − HCV D Ab±, NAT+ / R Ab −
Center 2015 2016 2017 2018 ALL Center 2015 2016 2017 2018 ALL
1 1 2 3 1 10 23 9 42
2 3 3 2 37 37
3 1 5 6 3 24 24
5 1 1 4 14 14
7 2 1 1 2 6 5 8 1 1 10
8 1 1 6 6 4 10
9 1 1 7 4 1 1 6
10 1 1 8 2 2 1 5
13 1 2 3 9 3 2 5
16 2 2 10 1 3 4
17 1 1 11 1 3 4
18 1 1 12 3 1 4
19 7 7 13 3 3
21 1 1 14 2 1 3
22 1 1 15 3 3
34 4 25 25 54 16 2 2
35 28 13 41 17 1 1 2
36 21 11 32 18 1 1 2
37 24 7 31 19 1 1 2
38 17 7 24 20 1 1
39 1 17 4 22 21 1 1
40 5 15 20 22 1 1
41 18 18 23 1 1
42 5 12 17 24 1 1
43 1 15 16 25 1 1
44 2 9 11 26 1 1
45 1 4 5 27 1 1
46 1 4 5 28 1 1
47 4 4 29 1 1
48 4 4 30 1 1
49 2 2 31 1 1
50 2 2 32 1 1
51 1 1 33 1 1
52 1 1 ALL 14 39 46 97 196
53 1 1
54 1 1
55 1 1
56 1 1
ALL 7 14 170 161 352

Ab, antibody; D, Donor; HCV, Hepatitis C Virus; NAT, Nucleic acid testing; R, Recipient.